EP
Eversept Partners’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1M | Buy |
838,736
+142,237
| +20% | +$2.89M | 1.57% | 21 |
|
|
2025
Q1 | $12.6M | Sell |
696,499
-23,337
| -3% | -$424K | 1.28% | 25 |
|
|
2024
Q4 | $18.2M | Buy |
719,836
+154,934
| +27% | +$3.92M | 1.61% | 12 |
|
|
2024
Q3 | $19.2M | Sell |
564,902
-68,113
| -11% | -$2.32M | 1.32% | 18 |
|
|
2024
Q2 | $23.4M | Sell |
633,015
-78,100
| -11% | -$2.89M | 1.6% | 15 |
|
|
2024
Q1 | $29.8M | Sell |
711,115
-42,992
| -6% | -$1.8M | 1.99% | 13 |
|
|
2023
Q4 | $29.9M | Buy |
754,107
+165,964
| +28% | +$6.58M | 2.63% | 11 |
|
|
2023
Q3 | $16.2M | Sell |
588,143
-197,597
| -25% | -$5.44M | 1.37% | 17 |
|
|
2023
Q2 | $26.7M | Buy |
785,740
+96,064
| +14% | +$3.26M | 2.23% | 11 |
|
|
2023
Q1 | $24.8M | Buy |
689,676
+130,902
| +23% | +$4.71M | 1.73% | 13 |
|
|
2022
Q4 | $24.9M | Sell |
558,774
-67,598
| -11% | -$3.01M | 2.18% | 12 |
|
|
2022
Q3 | $17.6M | Buy |
626,372
+73,984
| +13% | +$2.08M | 1.53% | 13 |
|
|
2022
Q2 | $14.9M | Sell |
552,388
-84,065
| -13% | -$2.27M | 1.06% | 25 |
|
|
2022
Q1 | $21.7M | Buy |
636,453
+43,975
| +7% | +$1.5M | 1.66% | 17 |
|
|
2021
Q4 | $22.9M | Buy |
+592,478
| New | +$22.9M | 1.46% | 15 |
|
|
2020
Q4 | – | Sell |
-150,494
| Closed | -$2.23M | – | 59 |
|
|
2020
Q3 | $2.23M | Sell |
150,494
-562,204
| -79% | -$8.34M | 0.5% | 34 |
|
|
2020
Q2 | $9.27M | Buy |
+712,698
| New | +$9.27M | 1.27% | 20 |
|